Errr. Years.It would first have to be proven better than the other commercial CPP as they admit; Q1'19.
Then it would have to jump through all the usual hoops; Phases 1, 2, 3.
Once you start "putting things into people", the TGA gets real, real, attentive.
If the things you are putting into people contain even part of a virus, they get really, really, really attentive.
But, it's a start.
All just MHO.
Ann: In vivo success - peptide vaccine in Herpes Simplex Virus, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |